Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Paula Coyle
  • September 24, 2018
  • Events

Pharma Market Research Conference Europe

Pharma Market Research Conference Europe

11-12 October 2018, Basel, Switzerland

We are delighted to be attending this year’s Pharma Market Research Conference in Basel, Switzerland in October. Representing Research Partnership will be Director Paula Coyle and Associate Director An-hwa Lee.
At the exhibition Paula and An-hwa will be on hand to talk about RP Informs, our range of free, customisable tutorials specifically designed to help improve your understanding of the issues affecting healthcare market research. Stop by to find out how you or your team could benefit from a complimentary market research training session.

read more »

  • Posted by Julie Denny
  • September 24, 2018
  • News

Announcing promotions and appointments across our offices

Announcing promotions and appointments across our offices

Research Partnership is delighted to announce promotions and new appointments in UK, San Francisco, Horsham and Singapore.

In our UK office, Jamie Laidlaw has been promoted to Associate Director. Since joining as a graduate in 2012 Jamie has risen through the ranks to become a highly skilled, dedicated and well-liked researcher. His outputs are consistently praised by both clients and directors alike. Jamie has also been a strong ambassador for Research Partnership in his instrumental role in graduate recruitment over the last two years. In our San Francisco office, Will Simpson has been promoted to Associate Director. Since the office opened last year, Will has proven to be an invaluable member of the team, and his contributions have been integral to its successes so far. His willingness to step up to a challenge and tireless enthusiasm for his work have really shone through.  Feedback from clients mirrors this, with many requesting him on their studies. In our Horsham office, Sagar Patel has been promoted to Senior Research Executive in our newly formed MedTech Division, headed up by Sabera Hyderally. Sagar has been with Research Partnership for 2 years, and in that time has shown himself to be a highly conscientious and dedicated researcher with good attention to detail and project management skills across both qualitative and quantitative…

read more »

  • Posted by Marc Yates
  • September 20, 2018
  • Articles

Comparing apples and oranges: Is a global segmentation transferable?

Comparing apples and oranges: Is a global segmentation transferable?

When our clients are considering primary market research in emerging markets they typically face two challenges - a lack of good local data and budget.

The absence of reliable and up-to-date information in emerging markets should mean that a greater budget is allocated to primary market research. However, in reality the opposite is true. Consequently, our clients want to know if they can tailor global studies to reflect the nuances of different emerging markets.

read more »

How we assessed the access potential of a new product in order to develop a successful launch strategy

How we assessed the access potential of a new product in order to develop a successful launch strategy

Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.

To ensure a fast and successful launch they wanted to develop key strategies to maximise acceptance and reimbursement of their product amongst HCPs and Payers. 

read more »

How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America

How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America

Our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.

At offered prices, it would be cost-effective and have comparable / lower net budget impact than analogues. However, payers in Latin America were still expected to add further barriers or reject the reimbursement request. As a result our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.

read more »